Quantitative phosphoproteomic analysis of host responses in human lung epithelial (A549) cells during influenza virus infection

Virus Research

Volumn 179, Issue 1, 2014, Pages 53-63

  Dapat, Clyde ^a   Saito, Reiko ^a   Suzuki, Hiroshi ^b   Horigome, Tsuneyoshi ^c  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA SEIRYO UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Host cell response; Influenza A virus; ITRAQ; LC MS MS; Quantitative phosphoproteomics

Indexed keywords

PHOSPHOPEPTIDE; PHOSPHOPROTEIN;

ARTICLE; CELL STRAIN A549; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE ONTOLOGY; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; QUANTITATIVE PHOSPHOPROTEOMICS; RNA PROCESSING; UPREGULATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY;

INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

HOST CELL RESPONSE; INFLUENZA A VIRUS; ITRAQ; LC-MS/MS; QUANTITATIVE PHOSPHOPROTEOMICS;

HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84892830474     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.11.012     Document Type: Article

References (43)

1. Anderson L., Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18:533-537.
2. Baas T., Baskin C.R., Diamond D.L., García-Sastre A., Bielefeldt-Ohmann H., Tumpey T.M., Thomas M.J., Carter V.S., Teal T.H., Van Hoeven N., Proll S., Jacobs J.M., Caldwell Z.R., Gritsenko M.A., Hukkanen R.R., Camp D.G., Smith R.D., Katze M.G. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 2006, 80:10813-10828.
3. Bader G.D., Hogue C.W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003, 4:2.
4. Bindea G., Mlecnik B., Hackl H., Charoentong P., Tosolini M., Kirilovsky A., Fridman W.H., Pagès F., Trajanoski Z., Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25:1091-1093.
5. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., Adams D.J., Xavier R.J., Farzan M., Elledge S.J. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.
6. Bretaña N.A., Lu C.T., Chiang C.Y., Su M.G., Huang K.Y., Lee T.Y., Weng S.L. Identifying protein phosphorylation sites with kinase substrate specificity on human viruses. PLoS One 2012, 7:e40694.
7. Coombs K.M., Berard A., Xu W., Krokhin O., Meng X., Cortens J.P., Kobasa D., Wilkins J., Brown E.G. Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J. Virol. 2010, 84:10888-10906.
8. Dapat I.C., Dapat C., Baranovich T., Suzuki Y., Kondo H., Shobugawa Y., Saito R., Suzuki H., Group J.I.C.S. Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One 2012, 7:e36455.
9. de Chassey B., Meyniel-Schicklin L., Aublin-Gex A., André P., Lotteau V. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery. Mol. Biosyst. 2012, 8:1297-1303.
10. Deyde V., Xu X., Bright R., Shaw M., Smith C., Zhang Y., Shu Y., Gubareva L., Cox N., Klimov A. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 2007, 196:249-257.
11. Dove B.K., Surtees R., Bean T.J., Munday D., Wise H.M., Digard P., Carroll M.W., Ajuh P., Barr J.N., Hiscox J.A. A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture. Proteomics 2012, 12:1431-1436.
12. Garten R., Davis C., Russell C., Shu B., Lindstrom S., Balish A., Sessions W., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C., Emery S., Hillman M., Rivailler P., Smagala J., de Graaf M., Burke D., Fouchier R., Pappas C., Alpuche-Aranda C., López-Gatell H., Olivera H., López I., Myers C., Faix D., Blair P., Yu C., Keene K., Dotson P.J., Boxrud D., Sambol A., Abid S., St George K., Bannerman T., Moore A., Stringer D., Blevins P., Demmler-Harrison G., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H., Belongia E., Clark P., Beatrice S., Donis R., Katz J., Finelli L., Bridges C., Shaw M., Jernigan D., Uyeki T., Smith D., Klimov A., Cox N. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
13. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., Ahlquist P., Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454:890-893.
14. Hauge S., Dudman S., Borgen K., Lackenby A., Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg. Infect. Dis. 2009, 15:155-162.
15. Hornbeck P.V., Kornhauser J.M., Tkachev S., Zhang B., Skrzypek E., Murray B., Latham V., Sullivan M. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012, 40:D261-D270.
16. Huang d.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
17. Huang d.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
18. Hurt A.C., Hardie K., Wilson N.J., Deng Y.M., Osbourn M., Gehrig N., Kelso A. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N. Engl. J. Med. 2011, 365:2541-2542.
19. Hutchinson E.C., Denham E.M., Thomas B., Trudgian D.C., Hester S.S., Ridlova G., York A., Turrell L., Fodor E. Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry. PLoS Pathog. 2012, 8:e1002993.
20. Iwase Y., Honma S., Matsuzaki M., Miyakawa Y., Kanno T., Ishii K., Furuichi N., Furukawa K., Horigome T. A fully automated phosphopeptide purification system for large-scale phosphoproteome analysis. J. Biochem. 2010, 147(5):689-696.
21. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., Mäurer A.P., Müller E., Wolff T., Rudel T., Meyer T.F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
22. Kroeker A.L., Ezzati P., Halayko A.J., Coombs K.M. Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study. J. Proteome Res. 2012, 11:4132-4146.
23. König R., Stertz S., Zhou Y., Inoue A., Hoffmann H.H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., Gao Q., Andrews S.E., Bandyopadhyay S., De Jesus P., Tu B.P., Pache L., Shih C., Orth A., Bonamy G., Miraglia L., Ideker T., García-Sastre A., Young J.A., Palese P., Shaw M.L., Chanda S.K. Human host factors required for influenza virus replication. Nature 2010, 463:813-817.
24. Lamb R.A., Krug R.M. Orthomyxoviridae: the viruses and their replication. Fields' Virology 2001, 1487-1531. Lippincott Williams & Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley (Eds.).
25. Lietzén N., Ohman T., Rintahaka J., Julkunen I., Aittokallio T., Matikainen S., Nyman T.A. Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog. 2011, 7:e1001340.
26. Liu L., Zhou J., Wang Y., Mason R.J., Funk C.J., Du Y. Proteome alterations in primary human alveolar macrophages in response to influenza a virus infection. J. Proteome Res. 2012, 11:4091-4101.
27. Ludwig S. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol. Chem. 2011, 392:837-847.
28. Ludwig S., Ehrhardt C., Neumeier E.R., Kracht M., Rapp U.R., Pleschka S. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 2001, 276:10990-10998.
29. Maruoka S., Hashimoto S., Gon Y., Nishitoh H., Takeshita I., Asai Y., Mizumura K., Shimizu K., Ichijo H., Horie T. ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem. Biophys. Res. Commun. 2003, 307:870-876.
30. Navratil V., de Chassey B., Meyniel L., Delmotte S., Gautier C., André P., Lotteau V., Rabourdin-Combe C. VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks. Nucleic Acids Res. 2009, 37:D661-D668.
31. Pinto L.H., Lamb R.A. The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 2006, 281:8997-9000.
32. Saito R., Li D., Suzuki Y., Sato I., Masaki H., Nishimura H., Kawashima T., Shirahige Y., Shimomura C., Asoh N., Degawa S., Ishikawa H., Sato M., Shobugawa Y., Suzuki H. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season. J. Med. Virol. 2007, 79:1569-1576.
33. Samji T. Influenza A: understanding the viral life cycle. Yale J. Biol. Med. 2009, 82:153-159.
34. Schaefer M.H., Fontaine J.F., Vinayagam A., Porras P., Wanker E.E., Andrade-Navarro M.A. HIPPIE: integrating protein interaction networks with experiment based quality scores. PLoS One 2012, 7:e31826.
35. Schaefer M.H., Lopes T.J., Mah N., Shoemaker J.E., Matsuoka Y., Fontaine J.F., Louis-Jeune C., Eisfeld A.J., Neumann G., Perez-Iratxeta C., Kawaoka Y., Kitano H., Andrade-Navarro M.A. Adding protein context to the human protein-protein interaction network to reveal meaningful interactions. PLoS Comput. Biol. 2013, 9:e1002860.
36. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
37. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., Hill D.E., Regev A., Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
38. Shaw M.L. The host interactome of influenza virus presents new potential targets for antiviral drugs. Rev. Med. Virol. 2011, 21:358-369.
39. Stertz S., Shaw M.L. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect. 2011, 13:516-525.
40. Sugaya N. Widespread use of neuraminidase inhibitors in Japan. J. Infect. Chemother. 2011, 17:595-601.
41. Tian Q., Stepaniants S.B., Mao M., Weng L., Feetham M.C., Doyle M.J., Yi E.C., Dai H., Thorsson V., Eng J., Goodlett D., Berger J.P., Gunter B., Linseley P.S., Stoughton R.B., Aebersold R., Collins S.J., Hanlon W.A., Hood L.E. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol. Cell. Proteomics 2004, 3:960-969.
42. Viemann D., Schmolke M., Lueken A., Boergeling Y., Friesenhagen J., Wittkowski H., Ludwig S., Roth J. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J. Immunol. 2011, 186:164-173.
43. Watanabe T., Watanabe S., Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7:427-439.